Fox Chase Cancer Center
Keystone Programs Home
Personalized Kidney Cancer Therapy
» The Plan
» The Potential
The Team
Mary B. Daly
Margie L. Clapper
Epigenetics and Progenitor Cells
Blood Cell Development and Cancer
External Scientific Advisory Panel
Biographies
FAQs
News
Fox Chase Cancer Center Home
Keystone Home » The Keystone Program in Personalized Risk and Prevention

The Keystone Program in Personalized Risk and Prevention

The Team

Margie L. Clapper, Ph.D. (left), Mary B. Daly, M.D., Ph.D. (right)

Leader: Mary B. Daly, M.D., Ph.D.

Co-Leaders: Margie L. Clapper, Ph.D.

Members:Andrea M. Barsevick, R.N., D.N.Sc.

Angela R. Bradbury, M.D.

Paul Cairns, Ph.D.

Harry S. Cooper, M.D.

Elliot Coups, Ph.D.

Kathryn Evers, M.D.

Veda N. Giri, M.D.

Andrew K. Godwin, Ph.D.

Carolyn Heckman, Ph.D.

Alfred G. Knudson Jr., M.D., Ph.D.

Warren D. Kruger, Ph.D.

Amy Lazev, Ph.D.

Stuart R. Lessin, M.D.

Sharon L. Manne, Ph.D.

Sibele I. Meireles, Ph.D.

Mark A. Morgan, M.D.

Clifford S. Perlis, M.D.

Mary E. Ropka, Ph.D., R.N.

Eric A. Ross, Ph.D.

Jose Russo, M.D.

Joseph R. Testa, Ph.D.

Michael Unger, M.D.

Robert G. Uzzo, M.D.

David S. Weinberg, M.D.

Michael Yu, M.D.